Neurosterix

About Neurosterix

Neurosterix is a biopharmaceutical company dedicated to developing allosteric modulators for treating neurological disorders. Their drug discovery platform focuses on creating novel drug candidates that improve efficacy, safety, and tolerability for patients with underserved neurological conditions.

Products & Services

Allosteric Modulators:Molecules designed to modulate the activity of target receptors by binding outside the active site, offering potential improvements in efficacy, safety, and tolerability for neurological disorder treatments.

Specialties

Allosteric Modulators Neurological Disorders Drug Discovery and Development

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 63000000 MR: - FA: $63M FAN: 63000000	D: 2024-04-03 FD: 2024-04-03	3 investors

Series A Latest

2024-04-03

$63.0M

3 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Neurosterix Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised